HeartSciences (HSCSW) Cash from Financing Activities (2022 - 2026)

HeartSciences (HSCSW) has 5 years of Cash from Financing Activities data on file, last reported at $2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 1529.6% year-over-year to $2.9 million; the trailing twelve-month figure through Jan 2026 stood at $8.2 million (up 172.14% YoY), and the FY2025 full-year result was $2.7 million, down 73.57% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $2.9 million, up from $1.5 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $9.1 million in Q1 2024 and bottomed at -$121522.0 in Q1 2023.
• The 5-year median for Cash from Financing Activities is $782374.0 (2022), against an average of $1.8 million.
• The widest annual swing landed in 2023, when Cash from Financing Activities sank 106.32%; it then jumped 7610.17% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$116392.0 in 2022, then soared by 542.15% to $514629.0 in 2023, then soared by 269.53% to $1.9 million in 2024, then retreated by 20.66% to $1.5 million in 2025, then soared by 94.6% to $2.9 million in 2026.
• The last three Cash from Financing Activities figures came in at $2.9 million (Q1 2026), $1.5 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.

Peer Comparison